Effects of grisorixin on the distribution of thallium-201 and on the oxidative metabolism in cultured myocardial cells.
Previous experiments in the dog and guinea-pig have shown that grisorixin, a monocarboxylic ionophore, can significantly increase the coronary blood flow and the myocardial uptake of 201Tl, as well as have a stimulant effect on the heart. In this study, cultures of myocardial cells were used in order to isolate the cells from the vascular and extracardiac influences so that any ionophorous effect on 201Tl could be evidenced. The effects of grisorixin on the oxidative metabolism were simultaneously studied. The technique described by Harary was used to prepare the cultures. The activity of the 14CCO2 produced by oxidation of [14C]glucose and [14C]octanoate added to the medium of culture and the intra/extracellular ratio of 201Tl concentrations (Tl i/e) were measured. In the controls (n = 8), the Tl i/e was 40 +/- 10 while it was 17 +/- 6 (p less than 0.05) in the cells that received 201Tl and grisorixin at the same time (n = 4), and 19 +/- 5 (p less than 0.05) in the flasks where 201Tl was injected after grisorixin (n = 7). A significant decrease of the [14C]octanoate oxidation was found in the flasks treated with grisorixin (n = 4, -50 +/- 16%, p less than 0.01) while the [14C]glucose oxidation was not significantly lowered (n = 3; -11 +/- 12%). The conclusion is that grisorixin decreases both the intracellular concentration of 201Tl and the fatty-acids oxidation in cultured myocardial cells. The beneficial effects previously observed in vivo were probably the consequence of the strong coronary dilatation and of an indirect stimulation.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002210:Caprylates / Q000378:metabolism; D002478:Cells, Cultured; D003864:Depression, Chemical; D005947:Glucose / Q000378:metabolism; D006321:Heart / Q000000981:diagnostic imaging; D066298:In Vitro Techniques; D007476:Ionophores / Q000494:pharmacology*; D009206:Myocardium / Q000166:cytology* / Q000378:metabolism; D009550:Nigericin / Q000031:analogs & derivatives / Q000494:pharmacology*; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects*; D011868:Radioisotopes; D011877:Radionuclide Imaging; D051381:Rats; D011919:Rats, Inbred Strains; D013793:Thallium
D000900:Anti-Bacterial Agents; D002210:Caprylates; D007476:Ionophores; D011868:Radioisotopes; C010731:grisorixin; D013793:Thallium; D005947:Glucose; C031492:octanoic acid; D009550:Nigericin